Mercer Global Advisors
OCGN icon

Mercer Global Advisors’s Ocugen OCGN Stock Holding History

Mercer Global Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,456
Closed -$9.93K – 2233
2024
Q3 		$9.93K Buy
+10,456
New +$14.4K ﹤0.01% 1946

Other funds holding OCGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mercer Global Advisors's OCGN Position: Q4 2024 in Review

Mercer Global Advisors sold out of Ocugen (OCGN) in Q4 2024, closing a stake of 10,456 shares — an estimated $9.93K sold.

Mercer Global Advisors first reported a position in OCGN in Q3 2024 and held it in 1 quarter. The position peaked at $9.93K in Q3 2024. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2024.

  • Mercer Global Advisors reported no remaining Ocugen position as of Q4 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 10,456 Ocugen shares in Q4 2024, an estimated $9.93K.
  • Mercer Global Advisors first reported a position in Ocugen in Q3 2024 and held it in 1 quarter.
  • Mercer Global Advisors's Ocugen position peaked at $9.93K in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Ocugen as of Q4 2024.

Based on Mercer Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.